PD16-08 EFFECT OF CABAZITAXEL VS ABIRATERONE OR ENZALUTAMIDE ON PATIENT-REPORTED OUTCOMES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
2019 ◽
Vol 20
(4)
◽
pp. 556-569
◽
2016 ◽
Vol 13
(10)
◽
pp. 643-650
◽